Cisco and G42 Deepen US-UAE Technology Partnership to Build Secure, End-to-End AI Infrastructure in the UAE
News Summary: The announcement represents a significant step towards advancing secure AI infrastructure across UAE, aligned with the US-UAE AI Acceleration Partnership. Cisco will power, connect, and secure a large-scale AI cluster deployed by G42,...
Shanton Pharma Completes EOP2 Meeting with US FDA for Refractory Gout Program
SAP-001 is Shanton's lead investigational compound with First- and Best-in-Class potential in uncontrolled gout SINGAPORE and PRINCETON, N.J., Oct. 27, 2025 /PRNewswire/ -- Shanton Pharma, a clinical-stage biotech developing a novel treatment for...
Tsingke Biotech Participates in TIDES USA 2025, Demonstrates Full-Scale Oligonucleotide Synthesis Capabilities
BEIJING, June 5, 2025 /PRNewswire/ -- Tsingke Biotech recently participated in TIDES USA 2025, the leading international event for oligonucleotide and peptide therapeutics, held in San Diego from May 19 to 22. As a repeat exhibitor, Tsingke...
Where Excellence Meets Intelligence – ProPak China Celebrating its 30th anniversary in 2025
SHANGHAI, June 3, 2025/PRNewswire/ -- Organized by Sinoexpo Informa Markets, ProPak China 2025, the premier trade fair for the processing and packaging industry in China, is set to take place from June 24 to 26, 2025, at the National Exhibition and...
Caliway Announces Successful EOP2 Meeting with the FDA for CBL-514 in Reduction of Abdominal Subcutaneous Fat
- Caliway has completed the End-of-Phase 2 (EOP2) meeting with the U.S. FDA for CBL-514, the world's first investigational drug for large-area subcutaneous fat reduction developed under the 505(b)(1) regulatory pathway. - The company has received...
Yingli Pharma Announces Successful End-of-Phase 2 Meeting with FDA and Clearance of Global Multi-center Phase 3 Registration Study Design of Linperlisib for the Treatment of Relapsed and/or Refractory Peripheral T-cell Lymphoma
SAN FRANCISCO, April 1, 2025 /PRNewswire/ -- Shanghai Yingli Pharmaceutical Co., Ltd. (Yingli Pharma), a clinical stage biotechnology company developing oral small molecule drugs for cancer, metabolic, and immune diseases, announced today that it...
IBM Completes Acquisition of HashiCorp, Creates Comprehensive, End-to-End Hybrid Cloud Platform
HashiCorp's capabilities drive significant synergies across multiple strategic growth areas for IBM, including Red Hat, watsonx, data security, IT automation and Consulting ARMONK, N.Y., Feb. 27, 2025 /PRNewswire/ -- IBM (NYSE: IBM) today announced...
Four Points Pakuwon Indah Offers a Unique and Bubbly Holiday Escape in Surabaya
SURABAYA, Indonesia, Dec. 17, 2024 /PRNewswire/ -- It is already that time of the year. As the holiday season approaches, families are eager to create lasting memories with festive vacations, including relaxing hotel staycations. Four Points by...
BBTruck and Haulio Partner to Deliver Seamless, End-to-End Supply Chain Logistics from Sea to Shore
New strategic partnership to integrate BBTruck's globally pioneering supply chain and logistics technology platform with Haulio 's container haulage platform TAIPEI, Dec. 2, 2024 /PRNewswire/ -- BBTruck, a global leader in supply chain and logistics...
